Diazyme Laboratories announced today that the FDA has granted Diazyme 510(k) clearance to market its SMART HbA1c Assay on its new SMART Point of Care System for diabetes monitoring.
Read More
Testing is on the rise as deficiency is associated with cancer, stroke, osteoporosis, and other disorders.
Read MoreThe United States Patent and Trademark Office (USPTO) granted Epinex Diagnostics the patent for its primary technology, the G1A? Rapid Diabetes Monitoring Index Test.
Read More
As all forms of diabetes continue to increase in incidence, testing options also expand.
Read MoreHemoCue AB, a subsidiary of Quest Diagnostics Inc, announces that it has signed an agreement with MEC Dynamics Corp (MEC) for the exclusive distribution of the Avie(TM) A1c point-of-care test in the US and Europe.
Read More